Yan H - Search Results

1

Glioblastoma multiforme: a review of therapeutic targets.

Kanu OO, Mehta A, Di C, Lin N, Bortoff K, Bigner DD, Yan H, Adamson DC. Kanu OO, et al. Among authors: yan h. Expert Opin Ther Targets. 2009 Jun;13(6):701-18. doi: 10.1517/14728220902942348. Expert Opin Ther Targets. 2009. PMID: 19409033 Review.

2

Glioblastoma Multiforme Oncogenomics and Signaling Pathways.

Kanu OO, Hughes B, Di C, Lin N, Fu J, Bigner DD, Yan H, Adamson C. Kanu OO, et al. Among authors: yan h. Clin Med Oncol. 2009 Apr 8;3:39-52. doi: 10.4137/cmo.s1008. Clin Med Oncol. 2009. PMID: 19777070 Free PMC article.

3

Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress.

Lu Z, Zhou L, Killela P, Rasheed AB, Di C, Poe WE, McLendon RE, Bigner DD, Nicchitta C, Yan H. Lu Z, et al. Among authors: yan h. Cancer Res. 2009 Dec 1;69(23):9105-11. doi: 10.1158/0008-5472.CAN-09-2775. Epub 2009 Nov 17. Cancer Res. 2009. PMID: 19920201 Free PMC article.

4

Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a review.

Hodges TR, Choi BD, Bigner DD, Yan H, Sampson JH. Hodges TR, et al. Among authors: yan h. J Neurosurg. 2013 Jun;118(6):1176-80. doi: 10.3171/2013.3.JNS122282. Epub 2013 Apr 12. J Neurosurg. 2013. PMID: 23581583 Free PMC article. Review.

5

HDMX regulates p53 activity and confers chemoresistance to 3-bis(2-chloroethyl)-1-nitrosourea.

Jin G, Cook S, Cui B, Chen WC, Keir ST, Killela P, Di C, Payne CA, Gregory SG, McLendon R, Bigner DD, Yan H. Jin G, et al. Among authors: yan h. Neuro Oncol. 2010 Sep;12(9):956-66. doi: 10.1093/neuonc/noq045. Epub 2010 May 14. Neuro Oncol. 2010. PMID: 20472715 Free PMC article.

6

Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas.

Broderick DK, Di C, Parrett TJ, Samuels YR, Cummins JM, McLendon RE, Fults DW, Velculescu VE, Bigner DD, Yan H. Broderick DK, et al. Among authors: yan h. Cancer Res. 2004 Aug 1;64(15):5048-50. doi: 10.1158/0008-5472.CAN-04-1170. Cancer Res. 2004. PMID: 15289301

7

Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid.

Di C, Liao S, Adamson DC, Parrett TJ, Broderick DK, Shi Q, Lengauer C, Cummins JM, Velculescu VE, Fults DW, McLendon RE, Bigner DD, Yan H. Di C, et al. Among authors: yan h. Cancer Res. 2005 Feb 1;65(3):919-24. Cancer Res. 2005. PMID: 15705891

8

Mutant metabolic enzymes are at the origin of gliomas.

Yan H, Bigner DD, Velculescu V, Parsons DW. Yan H, et al. Cancer Res. 2009 Dec 15;69(24):9157-9. doi: 10.1158/0008-5472.CAN-09-2650. Cancer Res. 2009. PMID: 19996293 Free PMC article. Review.

9

MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation.

Hansen LJ, Sun R, Yang R, Singh SX, Chen LH, Pirozzi CJ, Moure CJ, Hemphill C, Carpenter AB, Healy P, Ruger RC, Chen CJ, Greer PK, Zhao F, Spasojevic I, Grenier C, Huang Z, Murphy SK, McLendon RE, Friedman HS, Friedman AH, Herndon JE 2nd, Sampson JH, Keir ST, Bigner DD, Yan H, He Y. Hansen LJ, et al. Among authors: yan h. Cancer Res. 2019 Jul 1;79(13):3383-3394. doi: 10.1158/0008-5472.CAN-18-1010. Epub 2019 Apr 30. Cancer Res. 2019. PMID: 31040154 Free PMC article.

10

IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain.

Lopez GY, Reitman ZJ, Solomon D, Waldman T, Bigner DD, McLendon RE, Rosenberg SA, Samuels Y, Yan H. Lopez GY, et al. Among authors: yan h. Biochem Biophys Res Commun. 2010 Jul 30;398(3):585-7. doi: 10.1016/j.bbrc.2010.06.125. Epub 2010 Jul 13. Biochem Biophys Res Commun. 2010. PMID: 20603105 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13,471 results

Search Page